We are glad to communicate that today we will join the event organized by Dg Energy of the @EU_Commission Emergency Roundtable on enhanced #ConsumerProtection in the context of #EnergyCrisis. For more information on @activecitnet's work on this topic 👉https://t.co/JV6kD2zSld
We are glad to announce that we are supporting the @Europarl_EN event titled “Driving Collaboration in the Fight against Antimicrobial Resistance: Going Further, Aiming Higher” #AMR on 15 November. For more information, please write to W͟e͟b͟e͟r͟ ͟S͟h͟a��n͟d͟w͟i͟c͟k͟ ͟t͟e͟a͟m͟
Within the context of the Revision of the Pharma Resistance against antimicrobial treatments places a considerable burden on healthcare systems, society and animal health. We will talk about that at the hybrid event, organized by Weber Shandwick and supported by @activecitnet
If we have the treatments, we must use these to care for patients otherwise it would cause a waste of investments, these are the words of Sarah Garner of the @WHO at the event at the @Europarl_EN speaking about #ATMPs and authorization barriers #PatientsRights#AccessToCare
All potentially eligible patients have the right to #AccessToCare on #ATMPs and national health budget constraints cannot be a barrier to this. At @Europarl_EN a potential economic-accounting solution driven by Italian experts & endorsed by 43organizations https://t.co/sbcGELJsr0
Mauro Maré, public economics professor and panelist of the event at @Europarl_EN about ATMPs asks an important question: why should spending on #ATMPs be considered an annual expense if it has effects that go well beyond the year? #PatientsRights#AccessToCare
V. interesting debate at the EP. Should we consider ATMP as a capital investment rather than a cost? Can we adapt accounting systems to enable that investment to be paid in installments? A plea from panelists to find a way to explore new solutions. Thank you @activecitnet
🔵Don't miss "Securing Equitable Patient Access to Advanced Therapies across Europe" at the @Europarl_EN, follow the streaming starting at 4 pm today at the following link 👉https://t.co/2FH58JpKhy
#PatientsRights#AccessToCare#ATMPs
#VaccinAction
🔵Not just #COVID19: diseases such as meningitis, pneumococcal disease, herpes zoster, diphtheria, hepatitis and influenza can have serious consequences. Vaccination helps reduce the impact of these diseases
👉https://t.co/SsPjslymPr
What can you do to support our project “Winter is coming” for Ukraine 🇺🇦?
⬇️⬇️⬇️
✅ Like and Share
✅ Endorse
✅ Donate
Https://https://t.co/Rt1xgdwCbZ
#winteriscoming#supportukraine#orphansfeeding
#2lessons we have learned with #COVID19
1) Community engagement is a vital public health intervention during emergencies
2) Civil Society Organizations are key allies to build bridges between health authorities and communities and improve trust and resilience
Watch for more 👇
#ActiveCitizenshipNetwork’s monthly newsletter is out! This edition, among other issues, contains a civic reportage on the #health crisis in #Ukraine done by our Dutch partner @orphans_feeding. Do not miss it!
https://t.co/gSNfzqhoz8
A single #vaccine requires most of the time to have its own dedicated facility. It can take up to 10 years to start commercial manufacturing and distribution in a new facility. Read more on how this can impact #VaccinesSuppy: https://t.co/ausKJ6ZsxK #RC5 #WeWontRest @EFPIA @IFPMA single #vaccine requires most of the time to have its own dedicated facility. It can take up to 10 years to start commercial manufacturing and distribution in a new facility. Read more on how this can impact #VaccinesSuppy: https://t.co/ausKJ6ZsxK #RC5 #WeWontRest @EFPIA @IFPMA single #vaccine requires most of the time to have its own dedicated facility. It can take up to 10 years to start commercial manufacturing and distribution in a new facility. Read more on how this can impact #VaccinesSuppy: https://t.co/ausKJ6ZsxK #RC5#WeWontRest@EFPIA@IFPMA
We are proud to announce the #FACILITATEProject website is online!
Thanks to all who worked for this first achievement opening officially our FACILITATE project to the world!
Find out more about the project.
https://t.co/GD4Ju5jqNM
#IHI
In Europe, on average less than 0.5% of healthcare expenditure is allocated to routine #vaccines. Read more on how increasing vaccination budget could positively impact #VaccinesSupply and #access: https://t.co/WSCjwarTd0 #WeWontRest @msdeurope @EFPIIn Europe, on average less than 0.5% of healthcare expenditure is allocated to routine #vaccines. Read more on how increasing vaccination budget could positively impact #VaccinesSupply and #access: https://t.co/WSCjwarTd0 #WeWontRest @msdeurope @EFPIIn Europe, on average less than 0.5% of healthcare expenditure is allocated to routine #vaccines. Read more on how increasing vaccination budget could positively impact #VaccinesSupply and #access: https://t.co/WSCjwarTd0 #WeWontRest @msdeurope @EFPIA
Cancelling organised gatherings could be counterproductive to control #monekypox. These events are a powerful opportunity to engage with the population, communicate risks & provide targeted information🌈☀️🎶💓
Find more in @WHO_Europe & @ECDC_EU advice on summer events👇